FGFR-1 Variants in Human Breast Cancer
Author Information
Author(s): C Yiangou, H Cox, GS Bansal, R Coope, JJ Gomm, R Barnard, J Walters, N Groome, S Shousha, RC Coombes, CL Johnston
Primary Institution: Charing Cross and Westminster Medical School
Hypothesis
The study investigates the expression of different forms of fibroblast growth factor receptor 1 (FGFR-1) in normal and cancerous breast tissues.
Conclusion
The 106-kDa form of FGFR-1 is lost in malignant breast cancer cells, which may contribute to malignancy.
Supporting Evidence
- The 115-kDa beta form of FGFR-1 is predominantly expressed in both benign and malignant epithelial cells.
- The 106-kDa form of FGFR-1 is expressed in normal breast fibroblasts and myoepithelial cells but lost in malignant epithelial cells.
- FGFR-1 mRNA was detected in all breast cell populations, indicating its expression in fibroblasts.
- Immunohistochemistry confirmed the presence of FGFR-1 in normal and malignant breast tissues.
Takeaway
This study found that a specific form of a protein called FGFR-1 is missing in breast cancer cells, which might help explain why these cells grow uncontrollably.
Methodology
The study used Western blot analysis, RT-PCR, and immunohistochemistry to assess FGFR-1 expression in various breast cell lines and tissues.
Limitations
The study may not account for all possible mechanisms affecting FGFR-1 expression in breast cancer.
Participant Demographics
The study included samples from both malignant and non-malignant breast tissues.
Want to read the original?
Access the complete publication on the publisher's website